生物活性 | |||
---|---|---|---|
描述 | Orforglipron, also known as LY3502970, is a GLP-1 receptor agonist derived from patent WO2018056453A1. Orforglipron has multiple effects such as dependent delayed gastric emptying and feeding inhibition[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.13mL 0.23mL 0.11mL |
5.66mL 1.13mL 0.57mL |
11.33mL 2.27mL 1.13mL |
参考文献 |
---|
[1]Pyrazolopyridine derivative having glp-1 receptor agonist effect. WO2013046136A1. |